Serum concentration of tumor necrosis factor in patients with breast cancer

By Sheen-Chen S-M.   Chen W-J.   Eng H-L.   Chou F-F.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 3, 1997-05 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer

By Martin Lesley-Ann  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 829-836

Springer Publishing Company

Access to resources Recommend Favorite

Relationship Between Cathepsin D and Other Pathological and Biological Parameters in 1752 Patients With Primary Breast Cancer

By Gion M.   Mione R.   Dittadi R.   Romanelli M.   Pappagallo L.   Capitanio G.   Friede U.   Barbazza R.   Visona A.   Dante S.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite

Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy

By                

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1475-1482

Spandidos Publications

Access to resources Recommend Favorite

Bisphosphonate Therapy for Patients with Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 3, 2005-01 ,pp. : 217-225

Bentham Science Publishers

Access to resources Recommend Favorite